[Aminoglycosides to critically ill patients]

Ugeskr Laeger. 2004 Oct 11;166(42):3733.
[Article in Danish]
No abstract available

MeSH terms

  • Aminoglycosides / administration & dosage
  • Aminoglycosides / therapeutic use*
  • Critical Illness*
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Humans
  • Lactams / administration & dosage
  • Lactams / therapeutic use*
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / microbiology
  • Pseudomonas Infections / mortality
  • Pseudomonas aeruginosa / drug effects
  • Sepsis / drug therapy*
  • Sepsis / microbiology
  • Sepsis / mortality

Substances

  • Aminoglycosides
  • Lactams